INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Life Sci Alliance. 2023 Feb 6;6(4). doi: 10.26508/lsa.202201494. Print 2023 Apr.
NLRP3 is a pattern recognition receptor with a well-documented role in inducing inflammasome assembly in response to cellular stress. Deregulation of its activity leads to many inflammatory disorders including gouty arthritis, Alzheimer disease, and cancer. Whereas its role in the context of cancer has been mostly explored in the immune compartment, whether NLRP3 exerts functions unrelated to immunity in cancer development remains unexplored. Here, we demonstrate that NLRP3 interacts with the ATM kinase to control the activation of the DNA damage response, independently of its inflammasome activity. NLRP3 down-regulation in both broncho- and mammary human epithelial cells significantly impairs ATM pathway activation, leading to lower p53 activation, and provides cells with the ability to resist apoptosis induced by acute genotoxic stress. Interestingly, NLRP3 expression is down-regulated in non-small cell lung cancers and breast cancers, and its expression positively correlates with patient overall survival. Our findings identify a novel non-immune function for NLRP3 in maintaining genome integrity and strengthen the concept of a functional link between innate immunity and DNA damage sensing pathways to maintain cell integrity.
NLRP3 是一种模式识别受体,其在细胞应激时诱导炎症小体组装方面的作用已有充分的文献记载。其活性失调可导致多种炎症性疾病,包括痛风性关节炎、阿尔茨海默病和癌症。尽管其在癌症中的作用主要在免疫领域中得到了探索,但 NLRP3 是否在癌症发生中发挥与免疫无关的功能仍未得到探索。在这里,我们证明 NLRP3 与 ATM 激酶相互作用,以独立于其炎症小体活性来控制 DNA 损伤反应的激活。在人支气管和乳腺上皮细胞中下调 NLRP3 会显著损害 ATM 途径的激活,导致 p53 激活降低,并使细胞能够抵抗急性遗传毒性应激诱导的细胞凋亡。有趣的是,NLRP3 在非小细胞肺癌和乳腺癌中的表达下调,并且其表达与患者总生存期呈正相关。我们的研究结果确定了 NLRP3 在维持基因组完整性方面的一种新的非免疫功能,并加强了固有免疫和 DNA 损伤感应途径之间存在功能联系的概念,以维持细胞完整性。